The USC School of Pharmacy has reorganized its administrative structure to augment its leadership and enhance the school’s continued ability to set vital trends for the pharmacy field.
Sarah Hamm-Alvarez, the Gavin S. Herbert Professor in Pharmaceutical Sciences, has been named vice dean for research and graduate affairs. She also serves as chair of the Department of Pharmacology and Pharmaceutical Sciences.
Kathleen A. Johnson PharmD ’78, the William A. and Josephine A. Heeres Professor in Community Pharmacy, is now vice dean for clinical affairs and outcome sciences. She will continue as chair of the Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics & Policy.
Kathleen Besinque has become assistant dean for curriculum and assessment. Fred Weissman PharmD ’63 will continue as associate dean for student and faculty affairs and admissions, and Ronald Alkana PharmD ’70 will continue as associate dean for graduate affairs and interdisciplinary graduate programs.
Michael Wincor PharmD ’78, has expanded his role to include the school’s technology activities as the new associate dean for technology and global initiatives. Meanwhile, Jeffery Goad PharmD ’94, MPH ’03 has been appointed vice chair for continuing professional development, credentialing and distance education at the school’s Titus Family Department. Cynthia White will continue in her role as associate dean of administrative affairs.
By uniting clinical affairs and outcome sciences, for example, the school acknowledges the growing emphasis on outcomes in the delivery of health care. Similarly, the combination of curriculum and assessment highlights the school’s commitment to continuously evaluate and revise its educational offerings to create new models in pharmacy education, as well as meet and exceed the requirements of the school’s accrediting body.
In addition to her role as vice dean, Hamm-Alvarez serves as director of the Office of Research Development for the Southern California Clinical and Translational Science Institute (CTSI), which was created through a $56.8 million grant from the National Institutes of Health (NIH). As director, she helps identify needs and opportunities in clinical and translational science, puts together interdisciplinary teams to address those needs and oversees the CTSI pilot grant program. She also leads a nationally recognized team conducting translational research in the area of lacrimal gland function and the diagnosis and treatment of dry-eye syndromes, for which she has received funding from the NIH since 1994.
Johnson has been pivotal in developing innovative practice models and expanding the school’s work in safety-net clinics. She has provided national leadership in the delivery of health care services to the uninsured, the poor and the homeless while helping garner significant grants and awards, including the American Pharmacists Association’s Pinnacle Award and the American Association of Colleges of Pharmacy’s Transformative Community Service Award.
She is uniquely qualified for her new role as vice dean for as she holds three degrees that provide her with perspectives from both the clinical and economic sides of health care. She also has served as a principal investigator on a variety of innovative research efforts to improve clinical outcomes.
Besinque has served as the school’s director of experiential programs, coordinating the placement of students in practice-based settings and developing teaching sites for the Pharm.D program. Her graduate work in education makes her especially suited to oversee the school’s assessment protocols.
She earned the 2011 California Society of Health-System Pharmacists’ Distinguished Service Award and practices in the area of outpatient community-based women’s health, including emergency contraception and menopause therapies.
Since 1969, Weissman’s emphasis has been in the advancement of pharmacy education, and he has helped develop numerous courses within the school’s curriculum. He also teaches an undergraduate course on medical controversies and the law.
Alkana, whose research focuses on developing new treatment strategies for alcoholism and drug abuse, will work with Hamm-Alvarez to provide graduate programming.
In his prior role as head of global initiatives, Wincor expanded the school’s international partnerships, visiting schools throughout Asia that were eager to expand clinical pharmacy programming, for example. He will continue with these global efforts while also focusing on enhancing the school’s technological capabilities and usage.
Goad will direct the school’s professional development program, as well as oversee the USC International Travel Health Clinic. In his new role, he plans to build an expanded slate of educational offerings for practicing pharmacists, including Web-based programming. He is president of the California Immunization Coalition.
“These appointments signal a new path in the USC School of Pharmacy’s long-standing leadership in pushing the pharmacy profession forward,” said Dean R. Pete Vanderveen. “The 21st century continues to bring tremendous changes to our profession, and we will remain ahead of the curve by helping pharmacists define themselves through expanding practice areas and using our expertise to better serve patients and optimize outcomes for a healthier society.”
More stories about: Pharmacy